ESC 2024 Insights


 

ESC 2024 Insights: Sacubitril/Valsartan Compared to Valsartan in Regressing Myocardial Fibrosis in Stage B Heart Failure: the REVERSE-LVH Trial

337 views
September 27, 2024
Comments 0
Login to view comments. Click here to Login